Gastroenterology
Volume 135, Issue 4 , Pages 1392-1413.e5, October 2008

American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease

  • Peter J. Kahrilas

      Affiliations

    • Department of Medicine, Gastroenterology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Nicholas J. Shaheen

      Affiliations

    • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    • ,
  • Michael F. Vaezi

      Affiliations

    • Department of Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, Tennessee

published online 17 September 2008.

Abbreviations used in this paper: AGA, American Gastroenterological Association, GERD, gastroesophageal reflux disease, H2RA, histamine2 receptor antagonist, PPI, proton pump inhibitor, USPSTF, US Preventive Services Task Force

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Address requests for reprints to: Chair, Clinical Practice and Economics Committee, AGA Institute National Office, c/o Membership Department, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920

 Supported by grant R01 DC00646 from the Public Health Service.

 Peter J. Kahrilas is a consultant for AstraZeneca and TAP Pharmaceutical Products, Inc. Nicholas J. Shaheen is on the speaker's bureau for AstraZeneca and is a consultant for AstraZeneca and TAP Pharmaceutical Products, Inc and receives support (grant/research) from AstraZeneca, TAP Pharmaceutical Products, Inc, Proctor&Gamble, CCS Medical and Barrx Medical. Michael F. Vaezi is on the speaker's bureau of AstraZeneca, a consultant for AstraZeneca, Santarus, and Restech, and receives support (grant/research) from TAP Pharmaceutical Products, Inc, AstraZeneca, and Restech.

PII: S0016-5085(08)01605-3

doi:10.1053/j.gastro.2008.08.044

Gastroenterology
Volume 135, Issue 4 , Pages 1392-1413.e5, October 2008